Impact drugs targeting cardiometabolic risk on the gut microbiota. Balvers M, van den Born BH, Levin E, Nieuwdorp M, et al. Curr Opin Lipidol 2021;32:38-54.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Balvers M, van den Born BH, Levin E, Nieuwdorp M, et al. Impact drugs targeting cardiometabolic risk on the gut microbiota. Curr Opin Lipidol 2021;32:38-54.
PMID: 33332920